Clinical Laboratory Scientists of Alaska Proudly present: Empowering Laboratory Professionals 2018 Annual Conference. April 18,19, 20, 2018

Transcription

1 Clinical Laboratory Scientists of Alaska Proudly present: Empowering Laboratory Professionals 2018 Annual Conference April 18,19, 20, 2018 Laboratory professionals are often referred to as some of the "unsung heroes" of healthcare. Working behind the scenes, we may not get recognition the doctors and nurses do, but that doesn't mean we shouldn't take steps to empower our profession. We invite you to the CLSA annual conference for a chance to get out of the lab and network with other laboratory professionals and vendors. Earn PACE continuing education credits, attend the social event to test your trivia knowledge, and above all meet and reunite with other laboratory professionals across Alaska. Together we are powerful, together we can test it! Wednesday evening - Exhibitors Reception 5:30 7:30 PM The exhibitors will have their booths set up and look forward to showing you the latest technologies in a fun and relaxed atmosphere. Without their generous support, this program would not be possible. The program committee encourages you to visit each booth. Who s Coming to the 2018 CLSA Exhibit Hall? The Binding Site, Inc ARUP Laboratory AUDIT Micro Control Hettich Instruments Millennium Health University of Washington Qiagen Alaska Scientific Quest Diagnostics DiaSorin Molecular TELCOR BioFire Diagnostics Drucker Diagnostics Henry Schein Ortho Clinical Diagnostics Siemens Greiner Bio-One Meridian Bioscience Delivery Express Thermo Scientific Beckman Coulter Sysmex America WSLH Proficiency Testing Bio-Rad Laboratories Horiba Medical Luminex Corporation BD Diagnostics Instrument Laboratories Photo permission of Anchorage Convention and Visitors Bureau (ACVB)

2 Educational Program Wednesday, April 18, 2018 Hilton Anchorage Hotel 500 W. 3rd Avenue Anchorage, AK Call HILTONS. Ask for the rate code for CLSA18 Rates are $ % tax for attendees Session 1 Wednesday 8:30-10:00 AM Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Patients with multiple myeloma (MM) and related plasma cell disorders often present with a myriad of non-specific symptoms, making diagnosis challenging. Traditional screening methods are insensitive, missing a significant percentage of these patients. The laboratory can play a key role in helping the clinician obtain a more accurate diagnosis with appropriate follow-up by adopting updated MM screening protocols recommended by the International Myeloma Working Group (IMWG) & National Comprehensive Cancer Network (NCCN). Compare traditional myeloma testing methods with current recommended protocols and describe how kappa and lambda free light chain analysis play a key role. Discuss the updated criteria for diagnosis of Multiple Myeloma and new recommendations for inclusion in routine practice. Explain why it is necessary to monitor both intact immunoglobulin paraprotein and serum free light chains in multiple myeloma. Dr. Ann L. Sherwood Director of Scientific Affairs, The Binding Site Binding Site Inc. Scholarships from CLSA One of the benefits of belonging to CLSA is the availability of scholarships. These monies can be used to attend meetings, local and national; college level classes, and continuing education. The two scholarships awarded by CLSA are the Sharon O'Meara CE Scholarship Fund and Dan Fieblekorn CE money for Delegates. We have the monies for these scholarships and we would love to award them. Applications can be obtained by calling or ing anyone on the CLSA Board of Directors. Updates to this program will be available online at Session 2 Wednesday 8:30 10:00 AM Dealing with Preanalytic Error Preanalytic error is a common problem for all laboratories with potential impact to the healthcare facility as a whole and, more importantly, the patient. There are several things to consider in recognizing and resolving these errors. This discussion will focus on the most common preanalytic errors that plague laboratories including hemolysis, pseudohyperkalemia and short draws as well as offer suggestions on troubleshooting and finding solutions for these laboratory challenges. Describe the troubleshooting process for preanalytic errors that occur in the laboratory path workflow. Discuss the most common errors including hemolysis, pseudohyperkalemia and short draws (quantity not sufficient) and how to resolve them. Identify factors that contribute to preanalytic error, e.g. Decentralized phlebotomy, IV and syringe draws, training and how to minimize the impact. Michelle McLean, MS MT(ASCP) BS Senior Product & Applications Manager Greiner Bio-One North America Inc. Session 3 Wednesday 10:15-11:45 AM Keynote: Life and Laboratories in Havana, Cuba: They CAN test it! Speaker will share day to day life challenges for Cubans. She will also describe the laboratories visited, from a neighborhood physician s office to a general hospital. Education of medical laboratory scientist will be discussed. Describe laboratory practice in Cuba. Describe challenges for day to day life in Cuba. Describe healthcare hierarchy in Cuba. Barbara Snyderman, BS, MLS (ASCP) cm DLM Senior Lab Specialist, Ortho Clinical Diagnostics ASCLS Past President Silent Auction and Exhibitor s Reception Wednesday 5:30-7:30 PM This year the silent auction benefits Magic Yarn Project and will be held during the Exhibitor s Reception. Please come and shop while you benefit a charitable cause.

3 Educational Program Wednesday April 18, Thursday April 19, 2018 Session 4 Wednesday 2:00-3:30 PM When Specimens Go Bad: Interpreting Chemistry Results for Accuracy Are the Chemistry results on Yoda accurate? Or is it something more sinister? Different specimen issues will be presented in reference to how they affect clinical chemistry results. Through discussion of examples and case studies technicians and scientists will (re) learn to recognize when chemistry results have gone bad. Name at least four specimen issues that contribute to inaccurate results. Explain the difference between contamination, IV contamination and diluted by fluid (s). Recognize when common chemistry results are inaccurate. Katie Yaniec, MT (ASCP) Lab Computer Specialist ANMC Cristi Simpson, MT (ASCP) Assistant Director Lab Opera- Session 7 Wednesday 3:45-5:15 PM Proficiency Testing Basics This presentation will include an overview of proficiency testing (PT) regulatory requirements, statistical analysis, and grading of results. There will also be examples of common PT failures and corresponding corrective actions. Identify the role of proficiency testing in the laboratory accreditation process. List different grading processes and identify the information provided on an evaluation report. Identify potential consequences of PT failures and the appropriate corrective actions to address them. Amanda Weiss, MT ASCP Program Coordinator at WSLH Proficiency Testing Session 5 Wednesday 2:00-3:30 PM Latent TB Screening with New Tools: IGRA Use and Results Interpretation. Latent tuberculosis infection (LTBI) is a condition in which a person is infected with Mycobacterium tuberculosis but does not currently have active tuberculosis disease. An estimated 10 to 15 million persons in the United States have LTBI. Because 5 to 10 percent of persons with LTBI are at risk of progressing to active disease, identification and treatment of LTBI are essential for the elimination of tuberculosis. Describe currently available tests for latent tuberculosis infection (LTBI), focusing on the newer, blood-based Interferon Gamma Release Assays (IGRA s) Explain the benefits and limitations of LTBI screening with both either TST or an IGRA and what are the current guidelines in utilization of either strategy Interpret results when screening special populations: low-risk healthcare workers as well as high-risk immunocompromised patients or suspects in a TB exposure Identify the availability and pricing expectations for these types of tests in Alaska. Session 8 Thursday 8:30-10:00 AM Cost-Effective Utilization of Urine Drug Testing for Chronic Pain Management Patients The costs associated with traditional urine drug testing models for pain management can be excessive due to inappropriate testing performed, such as reflex confirmation testing for all positive screen results that are not clinically useful. This presentation will describe cost effective strategies that eliminate unnecessary testing and inappropriate interpretations for pain management patients. Compare traditional workplace drug testing model with chronic pain management monitoring. Describe factors affecting costs associated with chronic pain management patient oversight. Discuss mass spectrometry hybrid urine drug screen. Compare of mass spectrometry to immunoassay Gordon Nelson Vice President, Chemistry Division Manager ARUP Laboratories. Reid Hadley Area Manager QIAGEN Session 6 Wednesday 3:45:-5:15 PM Validation, Verification and Qualification: What does it all mean? Steps will be presented and discussed to cover the validation of new laboratory analyzers and new tests. The presentation will begin with planning the equipment, qualification and test validation, aspects to consider, data to be collected, methods used to crunch the data, and end with interpreting the data for acceptability. Name the critical points to an Equipment Qualification Plan. List 5 must haves for any test validation. Discuss at least two methods for comparing correlation data. Cristi Simpson, MT (ASCP) Assistant Director Lab Operations ANMC Katie Yaniec, MT (ASCP) Lab Computer Specialist ANMC Session 9 Thursday 8:30 10:00 AM What s New with Venipuncture? Update on CLSI Revisions The Clinical Laboratory Standards Institute (CLSI) recently released a revision of the GP41 Standard, Collection of Diagnostic Venous Blood Specimens. The presentation will focus on what the changes are relative to the previous edition and what impact these changes may have on day to day specimen collection. Identify important changes to the CLSI Standard for venous blood collection. Understand the path of workflow for venipuncture. Discuss how revisions impact venous blood collection. Michelle McLean, MS MT(ASCP) BS Senior Product & Applications Manager Greiner Bio-One North America Inc.

4 Educational Program Thursday, April 19, 2018 Session 10 Thursday 10:15 11:45 AM Diagnostic Stewardship: Leveraging the Laboratory to Optimize Antibiotic Use and Reduce Resistance Diagnostic stewardship embraces coordinated guidance and interventions to improve appropriate use of microbiological diagnostics to guide therapeutic decisions. It should promote appropriate, timely diagnostic testing, including specimen collection, and pathogen identification and accurate, timely reporting of results to guide patient treatment. Laboratory involvement in stewardship optimizes antimicrobial use and reduces resistance. List lab and microbiology tests that contribute to optimizing stewardship. Discuss the general principles of diagnostic stewardship as they relate to preanalytic, analytic and postanalytic activities. Describe how accurate and representative antimicrobial resistance surveillance data informs treatment guidelines and promotes control and prevention strategies. Dr. Thaddus D. Wilkerson, Pharm.D. BCPS Director Statewide Antimicrobial Stewardship, Alaska Native Tribal Health Consortium Session 11 Thursday 10:15-11:45 AM History of Testing and Automation in Hematology The speaker will review hematology testing from the earliest practices. Describe the principles of the early Coulter Counter. Describe Technicon three-part differential instrument. Describer early hematology testing. Barbara Snyderman, BS, MLS (ASCP) cm DLM Senior Lab Specialist, Ortho Clinical Diagnostics Session 12 Thursday 2:00 3:30 PM Laboratory Diagnosis of Infectious diseases: Fast and Furious. This session will describe laboratory workflows pertaining to the adoption & integration of new, emerging, & advanced technologies within the clinical diagnostic Laboratory. Speaker will use data to compare & contrast the pre- & post-implementation of the new work flow to demonstrate patient care benefit. Cost considerations & benefits associated with the process of adopting & integrating various technologies will also be discussed. Describe examples where adoption and integration of new, emerging, or advance technologies have occurred and how the new processes were developed. Discuss the experience of a multidisciplinary team approach for the optimal integration of new technologies in clinical laboratory at Seattle children s hospital. Give examples of improved efficiency and improved patient outcomes with calculations for cost containment. Xuan Qin, PhD, D(ABMM) Director, Microbiology Lab Seattle Children s Hospital Session 13 and 15 Thursday 2:00-5:15PM Packaging and Shipping Category A Infectious Substances This presentation covers the basics of handling and shipping Category A, Category B and Exempt Human Specimens. List the regulators of shipping biological specimens in the U.S. and internationally. Explain how to categorize biological specimens for shipping. Describe how to properly package a Category A, B, or exempt human specimen for shipping. John Laurance Public Health Microbiologist State of Alaska Public Health Laboratory Session 14 Thursday 3:45-5:15 PM C. difficle Approaches...Two steps forward, one step back This presentation reviews test methodologies including Glutamate Dehydrogenase, Toxin EIA, and Nucleic Acid Amplification Techniques. Reviewing the pros and cons of different testing algorithms using these tests. A discussion of common pre-analytical testing pitfalls and potential solutions. The importance of the colonized host. Consideration of the roles in a multi-disciplinary C. difficle program including environmental services, nursing, laboratory, infection prevention, clinicians, education providers, pharmacy, and administration. Discuss different algorithmic approaches to C. difficile testing. Describe the multi-disciplinary roles in a C. difficle program. Discuss common preanalytical testing pitfalls and potential solutions. Jenny Mayo, MT(ASCP) Microbiology Supervisor Alaska Regional Hospital Photo by permission of ACVB

5 Educational Program Thursday, April 19, 2018 Friday, April Thursday Evening Social Event 6:00 PM Session 16 Friday 8:30-10:00AM But is it really clean? A microscopic perspective of the UAA public restroom Dinner and Trivia Challenge Come test your knowledge with fellow laboratorians at Trivia! Questions include information from vendors and the conference presentations. Couldn t make it to a presentation? Don t worry, there will be plenty of questions for you to utilize your useless knowledge on. A three course dinner is included with the ticket and of course first and second place prizes. Students will present their independent research project, from planning to implementation and writing. Faculty advisor will also discuss the advantages of undergraduate research in developing scholarship and professionalism in the laboratory. Discuss the application of microbial analysis of public facilities. Discuss the relevance of microbial growth towards potential pathogenic transfer. Describe the benefits of undergraduate research as it pertains to development of scholarship and leadership potential. Grace Leu Burke, MS, MT (ASCP) Assistant Professor, University of Alaska Anchorage UAA Students: Leslie Garcia, Lesly Mislang, Amanda Olson, Rachel Sanders and Dong Won Yu Session 17 Friday 10:15-11:45 AM CLSA goes to Washington D.C.: The political climate for CLS Professionals We Can Test It! Laboratory Mugs and T-shirts In March CLSA sent 2 members to Washington to join forces with other laboratory professionals to be the voice of Clinical Laboratory Science on the hill. Join us as we discuss the issues and what CLSA, ASCLS and you can do to advocate for our profession. Discuss the 2018 Laboratory Legislation and What you can do. Describe the Political Action Committee initiatives and drives. Discuss the Government Affairs Committee updates. Erin Frasher CLSA President Elect Courtney Bennetts, CLSA Student Representative The UAA MLS club designed the logo for the conference. To raise funds to cover student registration for the conference, the club is selling T-shirts and mugs. Mug s ordered when you register online for the conference are $15 each. There will be mugs for sale at the conference for $20. T-shirts with the logo will also be available for purchase at the conference for $25. Supplies are limited. Updates to this program will be available online at

6 Educational Program Friday April To become a member of CLSA/ASCLS go to the website at: CLSA General Meeting Friday 12:00-2:00 PM Nomination of officers, summary of past years activities, award presentations, the CLSA webpage, and more. Ashley Frost, CLSA President Session 19 Friday 3:45 5:15 PM Transfusion Service Case Studies: Patient Responder Dilemma Case study of a patient with multiple antibodies and a warm autoantibody. A description of the steps and methods required to resolve this case and provide acceptable red cells for infusion will be presented. Discuss the steps to take to resolve cases when multiple antibodies including a warm autoantibody are present and the patient requires blood. Describe the methods used to resolve cases with multiple antibodies and a warm autoantibody. Jack Smrdel MT(ASCP) SBB cm Transfusion Service Supervisor, Alaska Native Medical Center Blood Bank Topics: Red Cell Inventory Management and Reduction of Wastage: A Process Improvement Project A presentation describing the Blood Bank at JBER and the process to reduce red cell wastage with a related review of the literature. Measure an institution s efficiency of red cell unit usage. Identify potential causes of red cell unit wastage. Implement a process to reduce red cell unit wastage. FFP Treated Resistant Angioedema Presentation describing the use of Fresh Frozen Plasma to treat resistant angioedema. Includes a review of the therapeutic usage of FFP and some novel uses. Describe the therapeutic uses of FFP. Discuss the clinical presentation of angioedema. Discuss the use of FFP to treat resistant angioedema and other novel uses. Sylvia Schilling MT (ASCP) SBBCM Transfusion Services Technical Supervisor

7

8 Wednesday, April 18, Registration Break Topic: Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Speaker: Dr. Ann L. Sherwood #1 Topic: : Dealing with Preanalytic Error Speakers: Michelle McLean, MS MT(ASCP) BS # Keynote Address: Life and Laboratories in Havana, Cuba: They CAN test it! Speaker: Barbara Snyderman., MLS(ASCP)DLM # Lunch with Exhibitors Break Topic: When Specimens Go Bad: Interpreting Chemistry Results for Accuracy Speaker: Katie Yaniec, MT (ASCP) & Cristi Simpson MT (ASCP) # 4 Topic: Validation, Verification and Qualification: What does it all mean? Speaker: Cristi Simpson MT(ASCP) & Katie Yaniec, MT (ASCP) # Exhibitors Reception Silent Auction Topic Latent TB Screening with New Tools: IGRA Use and Results Interpretation Speaker: Reid Hadley #5 Topic: Proficiency Testing Basics Speaker: Amanda Weiss #7 Thursday, April 19, Registration Topic: Cost-Effective Utilization of Urine Drug Testing for Chronic Pain Management Patients Speaker: Gordon Nelson # 8 Topic: What s New with Venipuncture: Update on CLSI Revisions Speaker: Michelle McLean, MS MT(ASCP) BS Greiner Bio-One North America Inc. # Break Topic: Diagnostic Stewardship: Leveraging the Laboratory to Optimize Antibiotic Use and Reduce Resistance Speaker: Dr. Thaddus Wilkerson #10 Topic: History of Testing and Automation in Hematology Speaker: Barbara Snyderman # Lunch with Exhibitors Topic: Laboratory Diagnosis of Infectious diseases: Fast and Furious. Speaker: Xuan Qin, PhD, D(ABMM) #12 Topic: Packaging and Shipping Category A Infectious Substances Speaker: John Laurance, Public Health Microbiologist State of Alaska Public Health Laboratory # Break Topic: C. difficle Approaches...Two steps forward, one step back Speakers: Jenni Mayo # 14 Topic: Packaging and Shipping Category A Infectious Substances Continued Speaker: John Laurance, Public Health Microbiologist State of Alaska Public Health Laboratory # Social Event: Trivia Challenge Friday, April 20, Registration Topic: But is it really clean? A microscopic perspective of the UAA public restroom Speakers: Grace Leu Burke, Leslie Garcia, Lesly Mislang, Amanda Olson, Rachel Sanders and Dong Won Yu # Break Topic: Legislative Update Speakers: Erin Frasher and Courtney Bennetts # Lunch and General Meeting Break Topic: Blood Bank Topics: Red Cell Inventory Management and Reduction of Wastage: A Process Improvement Project and FFP Treated Resistant Angioedema Speakers Sylvia Schilling # Topic: Transfusion Service Case Studies: Patient Responder Dilemma Speaker:Jack Smrdel, MT(ASCP)SBB # 19

9 Empowering Laboratory Professionals April 18-20, 2018 at the Hilton Hotel, Anchorage, Alaska To qualify for early registration rates go on-line to: It is quick, easy and saves on paper and postage! Or mail this form. Name: ASCLS # Address: Facility: Phone: (Required) I am willing to be a moderator: Yes No I will help at the registration desk Yes No Check here if you DO NOT want your name and to be given to vendors: Circle the sessions you will be attending: Wednesday 1, 2, 3, 4, 5, 6, 7 Thursday,8, 9, 10, 11, 12, 13, 14, 15 Friday 16, 17, 18, 19 CLSA is an approved provider of Continuing Education Programs in the Clinical Laboratory Sciences through the ASCLS P.A.C.E program. CLSA also provides credit for California Licensure for all sessions. Advance purchase only for the lunches. On site purchase will NOT be available. There is an additional fee of $5 per session for registration on 4/1/16 and after, so register early. CLSA is offering discount prices to active military members. Proper identification will need to be provided at the registration desk to claim the discounted rate. Member of ASCLS Before 4/1/2018 4/1/2018 and after By the 1.5 hour session $35 $ Active Military By the 1.5 hour $ Non-Member, non-military By the 1.5 hour session $ Student $ By the 1.5 hour session Lunch (included in full day registration) $30 $ Social Event - Trivia Challenge $55 $ ASCLS Member 3 Day Pass Includes 4 sessions/day and lunch all 3 days $300 $325 $ Total $ For mail-in registration, make check or money order, payable to CLSA. If your fees are being paid by a third party, PLEASE make sure they put your name on the check. If mailing registration, send to: Tony Gregston, 535 E 6th Ave Anchorage, AK 99501

10 CLINICAL LABORATORY SCI ENTI STS OF ALASKA CLSA Program Chair Shannon Billings 3603 Young Street Anchorage, AK 99508